Observational evidence of the treatment efficacy of IVIG as maintenance therapy for pediatric MOGAD

Daniel Griffiths-King; Evangeline Wassmer; Sukhvir Wright

doi:10.1016/j.ejpn.2025.10.014

Observational evidence of the treatment efficacy of IVIG as maintenance therapy for pediatric MOGAD

Daniel Griffiths-King^*
, Evangeline Wassmer
, Sukhvir Wright

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

Abstract

In children with MOGAD, relapse risk is significant - estimated between 17 and 40 %. Maintenance therapy is now widely recommended after the second attack, to prevent further relapses [1]. However, high quality evidence comparing the efficacy of different maintenance therapies in paediatrics remains limited, and clinicians with expertise in pediatric MOGAD remain divided on optimal strategies...

Original language	English
Pages (from-to)	A3
Journal	European Journal of Paediatric Neurology
Volume	59
Early online date	30 Oct 2025
DOIs	https://doi.org/10.1016/j.ejpn.2025.10.014
Publication status	Published - Nov 2025

Access to Document

10.1016/j.ejpn.2025.10.014

Cite this

@article{9d3116c25253400b90a7ece9f9cda3ea,

title = "Observational evidence of the treatment efficacy of IVIG as maintenance therapy for pediatric MOGAD",

abstract = "In children with MOGAD, relapse risk is significant - estimated between 17 and 40 \%. Maintenance therapy is now widely recommended after the second attack, to prevent further relapses [1]. However, high quality evidence comparing the efficacy of different maintenance therapies in paediatrics remains limited, and clinicians with expertise in pediatric MOGAD remain divided on optimal strategies...",

author = "Daniel Griffiths-King and Evangeline Wassmer and Sukhvir Wright",

year = "2025",

month = nov,

doi = "10.1016/j.ejpn.2025.10.014",

language = "English",

volume = "59",

pages = "A3",

journal = "European Journal of Paediatric Neurology",

issn = "1090-3798",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Observational evidence of the treatment efficacy of IVIG as maintenance therapy for pediatric MOGAD

AU - Griffiths-King, Daniel

AU - Wassmer, Evangeline

AU - Wright, Sukhvir

PY - 2025/11

Y1 - 2025/11

N2 - In children with MOGAD, relapse risk is significant - estimated between 17 and 40 %. Maintenance therapy is now widely recommended after the second attack, to prevent further relapses [1]. However, high quality evidence comparing the efficacy of different maintenance therapies in paediatrics remains limited, and clinicians with expertise in pediatric MOGAD remain divided on optimal strategies...

AB - In children with MOGAD, relapse risk is significant - estimated between 17 and 40 %. Maintenance therapy is now widely recommended after the second attack, to prevent further relapses [1]. However, high quality evidence comparing the efficacy of different maintenance therapies in paediatrics remains limited, and clinicians with expertise in pediatric MOGAD remain divided on optimal strategies...

UR - https://linkinghub.elsevier.com/retrieve/pii/S1090379825001643

UR - https://www.scopus.com/pages/publications/105020836654

U2 - 10.1016/j.ejpn.2025.10.014

DO - 10.1016/j.ejpn.2025.10.014

M3 - Editorial

C2 - 41188122

SN - 1090-3798

VL - 59

SP - A3

JO - European Journal of Paediatric Neurology

JF - European Journal of Paediatric Neurology

ER -

Observational evidence of the treatment efficacy of IVIG as maintenance therapy for pediatric MOGAD

Abstract

Access to Document

Other files and links

Fingerprint

Cite this